FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4256266464> ?p ?o ?g. }

• W4256266464 endingPage "S48" @default.
• W4256266464 startingPage "S47" @default.
• W4256266464 abstract "Treatment of depression with monoamine oxidase inhibitors (MAOIs) is complicated by the risk of drug interactions and possible serotonin syndrome if antidepressants with monoamine enhancement are used concomitantly. Esketamine nasal spray is a recently FDA approved antidepressant for individuals with treatment resistant depression and is to be used adjunctively with antidepressant pharmacotherapy. We report a patient who was successfully and safely treated with esketamine nasal spray while being treated with tranylcypromine.This patient was treated in our Center and data regarding blood pressure and side effect were reviewed from her clinical record.Baseline depression and anxiety ratings, including HAM A, QIDS, HAMD and MADRS, were in the range of moderate range of anxiety and depression. Baseline GAD 7 was only slightly elevated. At the end of the 4 week acute treatment phase (treatments of esketamine nasal spray twice weekly at doses ranging from 28 to 56 mg), all of her mood and anxiety ratings were in the normal range. Blood pressure usually increases during treatment with esketamine nasal spray, and increases during treatment were within the normal range and there was no evidence of hypertension. Esketamine nasal spray was well tolerated and there was no evidence of a serotonin syndrome.This is a single case report, but we review the literature of treatment of patients taking MAOIs with ketamine and with intravenous esketamine.Esketamine nasal spray appears to be a safe treatment even if administered to a patient being treated with tranylcypromine, an MAOI." @default.
• W4256266464 created "2022-05-12" @default.
• W4256266464 creator A5000349869 @default.
• W4256266464 creator A5012967975 @default.
• W4256266464 creator A5014334391 @default.
• W4256266464 creator A5023527028 @default.
• W4256266464 creator A5027581435 @default.
• W4256266464 creator A5029257842 @default.
• W4256266464 creator A5039651174 @default.
• W4256266464 creator A5042235544 @default.
• W4256266464 creator A5043115868 @default.
• W4256266464 creator A5047078649 @default.
• W4256266464 creator A5048266613 @default.
• W4256266464 creator A5058202616 @default.
• W4256266464 creator A5064844173 @default.
• W4256266464 creator A5073550391 @default.
• W4256266464 creator A5085501292 @default.
• W4256266464 creator A5091766408 @default.
• W4256266464 date "2019-12-01" @default.
• W4256266464 modified "2023-09-26" @default.
• W4256266464 title "P.038 Effect of esketamine nasal spray on cognition in patients with treatment-resistant depression: results from five phase-3 studies" @default.
• W4256266464 doi "https://doi.org/10.1016/j.euroneuro.2019.09.104" @default.
• W4256266464 hasPublicationYear "2019" @default.
• W4256266464 type Work @default.
• W4256266464 citedByCount "0" @default.
• W4256266464 crossrefType "journal-article" @default.
• W4256266464 hasAuthorship W4256266464A5000349869 @default.
• W4256266464 hasAuthorship W4256266464A5012967975 @default.
• W4256266464 hasAuthorship W4256266464A5014334391 @default.
• W4256266464 hasAuthorship W4256266464A5023527028 @default.
• W4256266464 hasAuthorship W4256266464A5027581435 @default.
• W4256266464 hasAuthorship W4256266464A5029257842 @default.
• W4256266464 hasAuthorship W4256266464A5039651174 @default.
• W4256266464 hasAuthorship W4256266464A5042235544 @default.
• W4256266464 hasAuthorship W4256266464A5043115868 @default.
• W4256266464 hasAuthorship W4256266464A5047078649 @default.
• W4256266464 hasAuthorship W4256266464A5048266613 @default.
• W4256266464 hasAuthorship W4256266464A5058202616 @default.
• W4256266464 hasAuthorship W4256266464A5064844173 @default.
• W4256266464 hasAuthorship W4256266464A5073550391 @default.
• W4256266464 hasAuthorship W4256266464A5085501292 @default.
• W4256266464 hasAuthorship W4256266464A5091766408 @default.
• W4256266464 hasConcept C118552586 @default.
• W4256266464 hasConcept C126322002 @default.
• W4256266464 hasConcept C139719470 @default.
• W4256266464 hasConcept C15744967 @default.
• W4256266464 hasConcept C162324750 @default.
• W4256266464 hasConcept C181199279 @default.
• W4256266464 hasConcept C185592680 @default.
• W4256266464 hasConcept C2776024655 @default.
• W4256266464 hasConcept C2776867660 @default.
• W4256266464 hasConcept C2777118369 @default.
• W4256266464 hasConcept C2777342061 @default.
• W4256266464 hasConcept C2778630814 @default.
• W4256266464 hasConcept C2779177272 @default.
• W4256266464 hasConcept C2780795376 @default.
• W4256266464 hasConcept C2780973058 @default.
• W4256266464 hasConcept C42219234 @default.
• W4256266464 hasConcept C55493867 @default.
• W4256266464 hasConcept C558461103 @default.
• W4256266464 hasConcept C71924100 @default.
• W4256266464 hasConcept C85663871 @default.
• W4256266464 hasConcept C98274493 @default.
• W4256266464 hasConceptScore W4256266464C118552586 @default.
• W4256266464 hasConceptScore W4256266464C126322002 @default.
• W4256266464 hasConceptScore W4256266464C139719470 @default.
• W4256266464 hasConceptScore W4256266464C15744967 @default.
• W4256266464 hasConceptScore W4256266464C162324750 @default.
• W4256266464 hasConceptScore W4256266464C181199279 @default.
• W4256266464 hasConceptScore W4256266464C185592680 @default.
• W4256266464 hasConceptScore W4256266464C2776024655 @default.
• W4256266464 hasConceptScore W4256266464C2776867660 @default.
• W4256266464 hasConceptScore W4256266464C2777118369 @default.
• W4256266464 hasConceptScore W4256266464C2777342061 @default.
• W4256266464 hasConceptScore W4256266464C2778630814 @default.
• W4256266464 hasConceptScore W4256266464C2779177272 @default.
• W4256266464 hasConceptScore W4256266464C2780795376 @default.
• W4256266464 hasConceptScore W4256266464C2780973058 @default.
• W4256266464 hasConceptScore W4256266464C42219234 @default.
• W4256266464 hasConceptScore W4256266464C55493867 @default.
• W4256266464 hasConceptScore W4256266464C558461103 @default.
• W4256266464 hasConceptScore W4256266464C71924100 @default.
• W4256266464 hasConceptScore W4256266464C85663871 @default.
• W4256266464 hasConceptScore W4256266464C98274493 @default.
• W4256266464 hasLocation W42562664641 @default.
• W4256266464 hasOpenAccess W4256266464 @default.
• W4256266464 hasPrimaryLocation W42562664641 @default.
• W4256266464 hasRelatedWork W1576755431 @default.
• W4256266464 hasRelatedWork W2048720449 @default.
• W4256266464 hasRelatedWork W2053996826 @default.
• W4256266464 hasRelatedWork W2075225619 @default.
• W4256266464 hasRelatedWork W2093284812 @default.
• W4256266464 hasRelatedWork W2113310701 @default.
• W4256266464 hasRelatedWork W2406180991 @default.
• W4256266464 hasRelatedWork W2949955873 @default.
• W4256266464 hasRelatedWork W3047486494 @default.
• W4256266464 hasRelatedWork W90674608 @default.
• W4256266464 hasVolume "29" @default.

• next